REAL PATIENTS SHARE THEIR EXPERIENCE

Meet Suzanne, Miho, and Susie. Like you, they are all too familiar with the experience of chronic constipation. Watch their videos to hear their stories, and find out how AMITIZA helped. Individual results may vary.

Get to know these real patients.
Get to know Suzanne, Miho, and Susie—real patients who were relieved they talked to their doctor and got a diagnosis.

Individual results may vary.

Play Video
Hear Susie discuss her CIC.
“After all this time my condition finally had a name.”
–Susie, patient with CIC

Individual results may vary.

Play Video
Hear Suzannne discuss her IBS-C.
“I would encourage you to go see your doctor...
you owe it to yourself.” –Suzanne, patient with IBS-C

Individual results may vary.

Play Video
Hear Miho talk about her CIC.
“I'm happy my doctor told me about AMITIZA.”
–Miho, patient with CIC

Individual results may vary.

Play Video
Get to know these real patients.

Individual results may vary.

Now
Playing
Hear Suzanne talk about her IBS-C.

Individual results may vary.

Now
Playing
Hear Susie discuss her CIC.

Individual results may vary.

Now
Playing
Hear Miho talk about her CIC.

Individual results may vary.

Now
Playing

Could your story inspire others like you?

If you’re taking AMITIZA for your condition, consider sharing your story. Your experience could inspire people with chronic constipation symptoms to talk to their doctor.

Real patients.
Real savings.

Register for an AMITIZA Savings Card to save on prescriptions and refills.

You’ll also receive tips and information about managing your condition.

Start saving

Talking to
your doctor

Sharing your history with chronic constipation helps your doctor find the treatment plan that is right for you. The Doctor Discussion Guide can help make the conversation more productive.

Create your guide

Taking
AMITIZA

Find out what to expect when taking AMITIZA.

Learn more

Uses & Important Safety Information

AMITIZA is for CIC in adults, OIC in adults with chronic, non-cancer pain, and IBS-C in women ≥ 18 years. Effectiveness in patients taking methadone has not been established.

Important Safety Information

AMITIZA (lubiprostone) is not for everyone. If you know or suspect you have a bowel blockage, do not take AMITIZA. If you are unsure, your healthcare provider (HCP) should evaluate your condition before starting AMITIZA.

Some patients taking AMITIZA may experience nausea. Take AMITIZA with food and water to reduce the occurrence of nausea.

Do not take AMITIZA if you have severe diarrhea. Some patients taking AMITIZA may experience diarrhea. If your diarrhea becomes severe, stop taking AMITIZA and tell your HCP.

Patients may experience fainting and low blood pressure after taking the first dose or repeated doses of AMITIZA. Stop taking AMITIZA and tell your HCP if these reactions occur. Symptoms usually go away before the next dose but may recur with repeated use. Tell your HCP if you are taking any medications to lower blood pressure. Other side effects such as diarrhea or vomiting may increase the risk of fainting and low blood pressure.

Within an hour of taking AMITIZA, a sensation of chest tightness and shortness of breath may occur. These symptoms usually go away within three hours, but may recur with repeated use. Tell your HCP if you experience these symptoms.

The most common side effects of taking AMITIZA 24 mcg twice daily for CIC are nausea, diarrhea, headache, abdominal pain, abdominal distension, and gas. The most common side effects of taking AMITIZA 24 mcg twice daily for Opioid-Induced Constipation are nausea and diarrhea. The most common side effects of taking AMITIZA 8 mcg twice daily for IBS-C are nausea, diarrhea, and abdominal pain. These are not all the side effects associated with AMITIZA.

Tell your HCP if you are taking a diphenylheptane opioid (e.g., methadone).

AMITIZA has not been studied in pregnant women. Based on animal studies, AMITIZA may cause fetal harm. AMITIZA should only be used during pregnancy if the potential benefits justify the potential risk to the fetus. If you are pregnant or become pregnant while being treated with AMITIZA, talk to your HCP to evaluate the risks to the fetus. Tell your HCP if you are nursing and monitor infants for diarrhea.

Tell your HCP if you have liver problems.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Indications

AMITIZA (lubiprostone) 24 mcg capsules twice daily is approved to treat Chronic Idiopathic Constipation (CIC) in adults. “Idiopathic” means the cause of the constipation is unknown and not due to an underlying illness or medication. AMITIZA 24 mcg twice daily is also approved to treat constipation caused by opioids (OIC), a type of prescription pain medicine, in adults with chronic, non-cancer pain. The effectiveness of AMITIZA has not been established if you are taking a diphenylheptane opioid (e.g., methadone). AMITIZA 8 mcg capsules twice daily is approved to treat Irritable Bowel Syndrome with Constipation (IBS-C) in women ≥18 years of age and older.

Please click here for complete Prescribing Information.